Natures Enterprise Value Over E B I T D A from 2010 to 2024

NMHIW Stock   0.01  0  29.63%   
Natures Miracle Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Natures Miracle Enterprise Value Over EBITDA regression line of quarterly data had r-squared of  0.57 and coefficient of variation of  70.10. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(539.55)
Current Value
(512.57)
Quarterly Volatility
2.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Natures Miracle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Natures Miracle's main balance sheet or income statement drivers, such as Tax Provision of 156.5 K, Interest Income of 491 or Depreciation And Amortization of 648 K, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 0.0 or Days Sales Outstanding of 85.89. Natures financial statements analysis is a perfect complement when working with Natures Miracle Valuation or Volatility modules.
  
Check out the analysis of Natures Miracle Correlation against competitors.

Latest Natures Miracle's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Natures Miracle Holding over the last few years. It is Natures Miracle's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Natures Miracle's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Natures Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean3,272
Coefficient Of Variation70.10
Mean Deviation1,871
Median4,548
Standard Deviation2,294
Sample Variance5.3M
Range6.3K
R-Value(0.75)
Mean Square Error2.5M
R-Squared0.57
Significance0
Slope(386.32)
Total Sum of Squares73.7M

Natures Enterprise Value Over E B I T D A History

2024 -512.57
2023 -539.55
2022 -1704.09
2021 1809.47

About Natures Miracle Financial Statements

Natures Miracle investors use historical fundamental indicators, such as Natures Miracle's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Natures Miracle. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(539.55)(512.57)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Natures Stock Analysis

When running Natures Miracle's price analysis, check to measure Natures Miracle's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natures Miracle is operating at the current time. Most of Natures Miracle's value examination focuses on studying past and present price action to predict the probability of Natures Miracle's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natures Miracle's price. Additionally, you may evaluate how the addition of Natures Miracle to your portfolios can decrease your overall portfolio volatility.